Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating diagnostic markers for joint infections in hip and knee surgeries

Official title: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Fluid Markers for the Diagnosis of Periprosthetic Hip and Knee Joint Infections

Run by Istituto Ortopedico Rizzoli · NCT04858217 · Data updated 2026-11-12

This study is testing if certain blood and joint fluid markers can help doctors quickly and accurately diagnose joint infections in patients having hip or knee revision surgeries.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment270 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedFebruary 1, 2022
Main results expectedJune 17, 2025
Study endsMarch 31, 2026
Registry record updatedSeptember 22, 2025
Trial IDNCT04858217 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients requiring hip or knee replacement surgery due to late joint prosthesis infection or non-infectious causes, with a history of at least 90 days since their initial surgery.

Probably not a fit

Patients with early joint prosthesis infections or those with infections in joints other than the hip or knee may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the diagnostic accuracy and cost-effectiveness of serum and synovial markers in identifying periprosthetic joint infections (PJI) in patients undergoing revision surgery for hip or knee replacements. By analyzing the combination of these biomarkers, the research seeks to improve the speed and accuracy of PJI diagnosis, which is crucial for determining the appropriate surgical strategy. The study will involve patients hospitalized for revision surgery, utilizing existing clinical data and laboratory examinations to evaluate the effectiveness of these markers.

Why it matters

Potential benefit: If successful, this study could lead to faster and more accurate diagnoses of joint infections, improving treatment outcomes for patients.

How similar studies have gone: Other studies have shown promise in using biomarkers for diagnosing infections, but this specific combination of serum and synovial markers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients requiring hip or knee replacement surgery: i) for 'late' joint prosthesis infection, present for at least 90 days from the date of the arthroplasty (first surgical phase); II) for non-infectious causes (mobilization, wear, instability, misalignment, adverse reactions to local tissues or other aseptic causes), also present for at least 90 days, and which have not had other re-operations on the same joint, and which will be a one-step review;
* Previous clinical data and laboratory and radiological examinations available.

Exclusion Criteria:

* Patients affected by 'early' joint prosthesis infection, with clinical symptom latency of less than 90 days (in this specific subset of patients there is in fact still considerable heterogeneity and little consensus about the diagnostic levels of white blood cell count and percentage of neutrophils).
* Patients suffering from joint prosthesis infection involving joints other than the hip or knee.
* Severe cognitive impairment or psychiatric disorders;
* Pregnant women.

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.